We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cryo-Save | LSE:CRYO | London | Ordinary Share | NL0009272137 | ORD EUR0.10 (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 420.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMCRYO
RNS Number : 4258J
Cryo-Save Group NV
30 March 2010
30 March 2010
Cryo-Save Group N.V
Director/PDMR Shareholding
Cryo-Save Group N.V.(AIM/Euronext: CRYO, 'Cryo-Save', or 'the Group'), Europe's
leading stem cell bank, has been informed today that Mr Johan Goossens,
Chairman, purchased 17,873 ordinary shares of Euro 0.10 ('Ordinary Shares') at a
price range between EUR5.60 and EUR5.84 between 23 March and 26 March 2010.
Following these purchases, Johan Goossens is beneficially interested in
1,630,000 ordinary shares, representing approximately 17.65% of the Group's
issued share capital.
Enquiries:
+------------------------------------+----------------------+
| Cryo-Save Group | + 31 (0)575 548998 |
+------------------------------------+----------------------+
| Marc Waeterschoot, Chief Executive | |
| Officer | |
+------------------------------------+----------------------+
| Arnoud van Tulder, Chief Financial | |
| Officer | |
+------------------------------------+----------------------+
| | |
+------------------------------------+----------------------+
| Daniel Stewart & Company plc | + 44 (0) 20 7776 |
| | 6550 |
+------------------------------------+----------------------+
| Simon Leathers/Emma Earl | |
+------------------------------------+----------------------+
| | |
+------------------------------------+----------------------+
| College Hill (UK) | + 44 (0) 20 7457 |
| | 2020 |
+------------------------------------+----------------------+
| Adrian Duffield/Rozi Morris | |
+------------------------------------+----------------------+
| | |
+------------------------------------+----------------------+
| SPJ Financiële Communicatie Amstelveen (NL) |
| +31 (0)20 647 8181 |
+-----------------------------------------------------------+
| Kees Jongsma/Léon Melens | |
+------------------------------------+----------------------+
About Cryo-Save
With more than 120,000 samples saved, Cryo-Save is the leading stem cell bank in
Europe and one of the fastest growing in the world. Driven by its international
business strategy, Cryo-Save is now represented in 38 countries on three
continents and has state-of-the-art processing facilities in Belgium, Germany,
Dubai, India and France (under construction).
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFELVDIIVII
1 Year Cryo-Save Chart |
1 Month Cryo-Save Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
